Table 2 Hazard ratios (HR) and 95% CI for associations of lipid biomarkers with total cancer mortality

TC^a

Ref

0.78 (0.60–1.00)

0.78 (0.61–1.01)

0.77 (0.59–0.99)

0.072

0.67 (0.47–0.95)

0.025

TC adjusted^b

Ref

0.74 (0.56–0.98)

0.77 (0.59–1.02)

0.71 (0.54–0.94)

0.036

0.62 (0.43–0.88)

0.009

Median^c

4.70/4.70/4.60

5.50/5.60/5.50

6.20/6.20/6.20

7.20/7.20/7.10

No of cases

187

158

170

177

HDL-C^a

Ref

0.83 (0.66–1.03)

0.86 (0.69–1.08)

0.56 (0.43–0.73)

<0.0001

0.67 (0.55–0.82)

0.0001

HDL-C adjusted^b

Ref

0.93 (0.73–1.18)

0.95 (0.74–1.22)

0.67 (0.50–0.91)

0.021

0.78 (0.62–0.98)

0.037

Median^c

0.95/0.90/1.20

1.20/1.10/1.50

1.50/1.40/1.80

2.00/1.80/2.10

No of cases

254

188

188

103

apo(a)^a

Ref

0.77 (0.60–0.97)

0.75 (0.59–0.95)

0.64 (0.50–0.82)

0.0007

0.56 (0.39–0.80)

0.001

apo(a) adjusted^b

Ref

0.76 (0.58–0.99)

0.80 (0.62–1.03)

0.71 (0.54–0.93)

0.029

0.67 (0.45–0.99)

0.044

Median^c

1.34/1.30/1.48

1.54/1.48/1.68

1.70/1.64/1.90

2.04/1.91/2.16

No of cases

224

169

183

156

apoB-100^a

Ref

0.84 (0.66–1.08)

0.73 (0.56–0.94)

0.87 (0.68–1.12)

0.284

0.82 (0.64–1.05)

0.112

apoB-100 adjusted^b

Ref

0.88 (0.68–1.15)

0.69 (0.52–0.91)

0.79 (0.60–1.03)

0.054

0.72 (0.56–0.93)

0.011

Median^c

0.82/0.84/0.77

1.03/1.07/0.97

1.21/1.26/1.15

1.47/1.53/1.38

No. of cases

173

178

160

204

TG^a

Ref

1.29 (1.00–1.67)

1.00 (0.77–1.29)

1.21 (0.94–1.56)

0.382

1.06 (0.95–1.19)

0.305

TG adjusted^b

Ref

1.28 (0.97–1.70)

0.92 (0.69–1.23)

1.10 (0.82–1.46)

0.895

0.97 (0.85–1.11)

0.675

Median^c

0.90/1.00/0.80

1.50/1.70/1.10

2.00/2.40/1.60

3.30/3.70/2.70

No of cases

153

173

162

200

Lp(a)^a

Ref

0.98 (0.77–1.25)

0.76 (0.59–0.98)

0.78 (0.60–1.00)

0.080

0.94 (0.90–0.99)

0.011

Lp(a) adjusted^b

Ref

0.94 (0.72–1.22)

0.73 (0.56–0.96)

0.74 (0.57–0.98)

0.076

0.94 (0.89–0.98)

0.010

Median^c

3.50/3.30/3.85

8.50/8.10/9.40

20.25/19.40/21.75

129.60/121.60/134.70

No of cases

189

187

160

157